MedPath

Effects of Aromatherapy on Patients Undergoing Chemotherapy for Breast Cancer

Not Applicable
Not yet recruiting
Conditions
Sleep Quality
Anxiety
Interventions
Other: Aromatherapy
Other: No intervention
Registration Number
NCT06338527
Lead Sponsor
Weifang Medical University
Brief Summary

The objective of this study was to investigate the effects of aromatherapy on sleep quality and anxiety in patients undergoing chemotherapy for breast cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
90
Inclusion Criteria
  1. patients diagnosed with breast cancer and receiving chemotherapy; 2) suffering from sleep disorders or PSQI score greater than 5; 3) not using medications such as antidepressants and hypnotics that may affect the observation results; 4) age older than 18 years and volunteered to participate in this study.
Exclusion Criteria
  1. Asthma or severe respiratory disease; 2) Allergy to lavender; 3) Cognitive or communication disorders; 4) Breast cancer combined with severe organ dysfunction.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental groupAromatherapyThe researchers placed 2 drops of lavender oil on gauze in a box each night 30 minutes before the patient went to bed and placed it 15 to 20 centimeters from the pillow.
Control groupNo interventionThe control group had no aromatherapy intervention during the study period.
Primary Outcome Measures
NameTimeMethod
Sleep qualityThe sleep quality of the patients was assessed at 8 a.m. for one week.

The Pittsburgh Sleep Quality Index (PSQI) was used to assess the sleeping quality of the patients. The total score of PSQI ranged from 0-21, with higher scores indicating poor sleep quality.

AnxietyThe anxiety level of the patients was assessed at 8 a.m. for one week.

Beck Anxiety Inventory (BAI) was used to assess the anxiety level of the patients. The scale consists of 21 entries with a total score ranging from 0 to 63, with higher total scores being associated with more severe levels of anxiety.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Weifang People's Hospital

🇨🇳

Weifang, Shangdong, China

© Copyright 2025. All Rights Reserved by MedPath